Collaborations & Alliances

CrownBio, Pierre Fabre In Immuno-Oncology Alliance

CrownBio to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Crown Bioscience has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline. CrownBio will leverage its collection of patient-derived xenograft (PDX) models and humanized solutions for immuno-oncology drug development to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models. These customized, humanized models will be used to help accelerate Pierre Fabre’s innovative immuno-oncology drug discove...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters